Genfleet Therapeutics (Shanghai) Inc.
Quick facts
Phase 3 pipeline
- GFH375 · Immunology
GFH375 is a small molecule inhibitor of the PI3K delta subunit.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: